CRYOPORT, INC. Finance Lease, Liability, to be Paid, Year Three
CRYOPORT, INC. (CYRX) had Finance Lease, Liability, to be Paid, Year Three of $154.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree · last filed 2026-08-06
- 2026-06-30: Finance Lease, Liability, to be Paid, Year Three $154.00K.
- 2026-03-31: Finance Lease, Liability, to be Paid, Year Three $102.00K.
- 2025-12-31: Finance Lease, Liability, to be Paid, Year Three $280.00K.
- 2025-09-30: Finance Lease, Liability, to be Paid, Year Three $280.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Three |
|---|---|
| 2026-06-30 | $154.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $102.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $280.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $280.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $281.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $199.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $456.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | $433.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $336.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $244.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $343.00K 10-K · filed 2024-03-13 |
| 2023-09-30 | $211.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $191.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $60.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $85.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $58.00K 10-Q · filed 2022-11-04 |
| 2020-12-31 | $60.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $56.21K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $58.58K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $56.44K 10-Q · filed 2020-05-08 |
| 2019-09-30 | $8.65K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $8.65K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $8.65K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |